Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis
- 28 February 2010
- journal article
- Published by Elsevier BV in Human Immunology
- Vol. 71 (2), 212-219
- https://doi.org/10.1016/j.humimm.2009.10.009
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expressionJournal of Leukocyte Biology, 2008
- Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruptionBMC Infectious Diseases, 2008
- Global diversity and evidence for coevolution of KIR and HLANature Genetics, 2007
- Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and RéunionTissue Antigens, 2005
- NK CELL RECOGNITIONAnnual Review of Immunology, 2005
- HLA alleles, IFN-γ responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosisHuman Immunology, 2004
- Failure of Gamma Interferon but Not Interleukin-10 Expression in Response to Human Papillomavirus Type 11 E6 Protein in Respiratory PapillomatosisClinical and Vaccine Immunology, 2004
- KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive ImmunityAnnual Review of Immunology, 2002
- Kinetics of HPV11 DNA replication after infection of keratinocytes with virionsVirus Research, 1996
- Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous γ-globulin therapy, and natural killer deficiencyClinical Immunology and Immunopathology, 1989